| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| CJMBCALLAN JMB INC. | 19.42M | 4.20 | -4.83 | -50.29% | -112.68% | -159.6% | 2.55% | 0.29 |
| CYRXCryoport, Inc. | 564.28M | 11.27 | -5.10 | -1.7% | 35.52% | 13.11% | 0.62 | |
| HKPDHong Kong Pharma Digital Technology Holdings Limited | 8.77M | 0.80 | -265.67 | 21.72% | -0.13% | -0.59% | 4.72% | 0.48 |
| Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|
| Sales/Revenue | 22.77M | 13.2M | 6.56M |
| Revenue Growth % | - | -0.42% | -0.5% |
| Cost of Goods Sold | 13.32M | 7.55M | 4M |
| COGS % of Revenue | 0.58% | 0.57% | 0.61% |
| Gross Profit | 9.45M | 5.65M | 2.56M |
| Gross Margin % | 0.42% | 0.43% | 0.39% |
| Gross Profit Growth % | - | -0.4% | -0.55% |
| Operating Expenses | 3.15M | 3.45M | 4.84M |
| OpEx % of Revenue | 0.14% | 0.26% | 0.74% |
| Selling, General & Admin | 3.15M | 3.33M | 4.64M |
| SG&A % of Revenue | 0.14% | 0.25% | 0.71% |
| Research & Development | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - |
| Other Operating Expenses | 0 | 116.95K | 194.69K |
| Operating Income | 6.3M | 2.2M | -2.27M |
| Operating Margin % | 0.28% | 0.17% | -0.35% |
| Operating Income Growth % | - | -0.65% | -2.03% |
| EBITDA | 6.37M | 2.3M | -2.13M |
| EBITDA Margin % | 0.28% | 0.17% | -0.32% |
| EBITDA Growth % | - | -0.64% | -1.92% |
| D&A (Non-Cash Add-back) | 68.49K | 102.8K | 143.69K |
| EBIT | 6.3M | 2.2M | -2.26M |
| Net Interest Income | -6.12K | 2.04K | 6.53K |
| Interest Income | 0 | 2.04K | 11.9K |
| Interest Expense | 6.12K | 0 | 5.37K |
| Other Income/Expense | -1.62K | 2.04K | 6.53K |
| Pretax Income | 6.3M | 2.2M | -2.27M |
| Pretax Margin % | 0.28% | 0.17% | -0.35% |
| Income Tax | 75K | 23K | 25.37K |
| Effective Tax Rate % | 0.99% | 0.99% | 1.01% |
| Net Income | 6.22M | 2.18M | -2.29M |
| Net Margin % | 0.27% | 0.17% | -0.35% |
| Net Income Growth % | - | -0.65% | -2.05% |
| Net Income (Continuing) | 6.22M | 2.18M | -2.29M |
| Discontinued Operations | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| EPS (Diluted) | 1.24 | 0.44 | -0.87 |
| EPS Growth % | - | -0.65% | -2.98% |
| EPS (Basic) | 1.24 | 0.44 | -0.87 |
| Diluted Shares Outstanding | 5M | 5M | 2.63M |
| Basic Shares Outstanding | 5M | 5M | 2.63M |
| Dividend Payout Ratio | 0.71% | 3.39% | - |
| Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|
| Total Current Assets | 14.37M | 8.45M | 3.32M |
| Cash & Short-Term Investments | 6.19M | 5.16M | 2.1M |
| Cash Only | 6.19M | 5.16M | 2.1M |
| Short-Term Investments | 0 | 0 | 0 |
| Accounts Receivable | 7.85M | 2.9M | 647.96K |
| Days Sales Outstanding | 125.85 | 80.15 | 36.03 |
| Inventory | 79.44K | 114.74K | 158.36K |
| Days Inventory Outstanding | 2.18 | 5.54 | 14.45 |
| Other Current Assets | 246.16K | 282.96K | 414.92K |
| Total Non-Current Assets | 881.51K | 1.25M | 1.76M |
| Property, Plant & Equipment | 877.86K | 1.25M | 1.76M |
| Fixed Asset Turnover | 25.93x | 10.57x | 3.73x |
| Goodwill | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 |
| Other Non-Current Assets | 3.65K | 3.65K | 3.65K |
| Total Assets | 15.25M | 9.71M | 5.08M |
| Asset Turnover | 1.49x | 1.36x | 1.29x |
| Asset Growth % | - | -0.36% | -0.48% |
| Total Current Liabilities | 1.11M | 769.71K | 1.28M |
| Accounts Payable | 667.63K | 313.95K | 878.04K |
| Days Payables Outstanding | 18.3 | 15.17 | 80.12 |
| Short-Term Debt | 110.29K | 115.88K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 |
| Other Current Liabilities | 161K | 171.11K | 100.7K |
| Current Ratio | 12.94x | 10.98x | 2.59x |
| Quick Ratio | 12.87x | 10.83x | 2.47x |
| Cash Conversion Cycle | 109.72 | 70.52 | -29.63 |
| Total Non-Current Liabilities | 129.25K | 140.56K | 628.27K |
| Long-Term Debt | 0 | 0 | 0 |
| Capital Lease Obligations | 129.25K | 132.49K | 628.27K |
| Deferred Tax Liabilities | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 8.07K | 0 |
| Total Liabilities | 1.24M | 910.27K | 1.91M |
| Total Debt | 410.88K | 400K | 907.45K |
| Net Debt | -5.78M | -4.76M | -1.19M |
| Debt / Equity | 0.03x | 0.05x | 0.29x |
| Debt / EBITDA | 0.06x | 0.17x | - |
| Net Debt / EBITDA | -0.91x | -2.06x | - |
| Interest Coverage | 1029.36x | - | -423.46x |
| Total Equity | 14.01M | 8.8M | 3.17M |
| Equity Growth % | - | -0.37% | -0.64% |
| Book Value per Share | 2.80 | 1.76 | 1.21 |
| Total Shareholders' Equity | 14.01M | 8.8M | 3.17M |
| Common Stock | 14.01M | 8.8M | 3K |
| Retained Earnings | 0 | 0 | -2.29M |
| Treasury Stock | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|
| Cash from Operations | 9.36M | 7M | 540.35K |
| Operating CF Margin % | 0.41% | 0.53% | 0.08% |
| Operating CF Growth % | - | -0.25% | -0.92% |
| Net Income | 6.22M | 2.18M | -2.29M |
| Depreciation & Amortization | 68.49K | 102.8K | 143.69K |
| Stock-Based Compensation | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 |
| Other Non-Cash Items | 101.69K | -41.35K | 354.09K |
| Working Capital Changes | 2.97M | 4.75M | 2.34M |
| Change in Receivables | 6.88M | 4.67M | 2.41M |
| Change in Inventory | 65K | -35.29K | -43.62K |
| Change in Payables | -1.1M | 0 | 0 |
| Cash from Investing | -422.49K | -490.02K | -46.17K |
| Capital Expenditures | -422.49K | -490.02K | -46.17K |
| CapEx % of Revenue | 0.02% | 0.04% | 0.01% |
| Acquisitions | - | - | - |
| Investments | - | - | - |
| Other Investing | 0 | 0 | 0 |
| Cash from Financing | -4.57M | -7.54M | -3.55M |
| Debt Issued (Net) | - | - | - |
| Equity Issued (Net) | - | - | - |
| Dividends Paid | -4.45M | -7.4M | -3.33M |
| Share Repurchases | - | - | - |
| Other Financing | 51.42K | -146.83K | -107.72K |
| Net Change in Cash | - | - | - |
| Free Cash Flow | 8.94M | 6.51M | 494.19K |
| FCF Margin % | 0.39% | 0.49% | 0.08% |
| FCF Growth % | - | -0.27% | -0.92% |
| FCF per Share | 1.79 | 1.30 | 0.19 |
| FCF Conversion (FCF/Net Income) | 1.51x | 3.21x | -0.24x |
| Interest Paid | 6.12K | 8.13K | 5.37K |
| Taxes Paid | 0 | 0 | 0 |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Return on Equity (ROE) | 44.4% | 19.13% | -38.33% |
| Return on Invested Capital (ROIC) | 57.4% | 26.92% | -56.66% |
| Gross Margin | 41.51% | 42.79% | 39.05% |
| Net Margin | 27.32% | 16.52% | -34.95% |
| Debt / Equity | 0.03x | 0.05x | 0.29x |
| Interest Coverage | 1029.36x | - | -423.46x |
| FCF Conversion | 1.51x | 3.21x | -0.24x |
| Revenue Growth | - | -42.01% | -50.29% |
CALLAN JMB INC. (CJMB) reported $5.9M in revenue for fiscal year 2024. This represents a 74% decrease from $22.8M in 2022.
CALLAN JMB INC. (CJMB) saw revenue decline by 50.3% over the past year.
CALLAN JMB INC. (CJMB) reported a net loss of $6.7M for fiscal year 2024.
Yes, CALLAN JMB INC. (CJMB) pays a dividend with a yield of 30.13%. This makes it attractive for income-focused investors.
CALLAN JMB INC. (CJMB) has a return on equity (ROE) of -38.3%. Negative ROE indicates the company is unprofitable.
CALLAN JMB INC. (CJMB) had negative free cash flow of $5.2M in fiscal year 2024, likely due to heavy capital investments.